ValiRx plc

VAL.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-£2,142-£2,299-£2,593-£1,678
Dep. & Amort.£267£254£212£229
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£37£540£185
Change in WC£143£46£0-£67
Other Non-Cash£147£189£129£71
Operating Cash Flow-£1,585-£1,772-£1,712-£1,261
Investing Activities
PP&E Inv.-£38-£291£0£0
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.£0-£15£0£0
Investing Cash Flow-£38-£306£0£0
Financing Activities
Debt Repay.-£10-£10-£13-£5
Stock Issued£3,375£1,300£2,487£22
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.-£360-£174-£218-£9
Financing Cash Flow£3,004£1,116£2,256£7
Forex Effect£0£0£0£0
Net Chg. in Cash£1,381-£963£544-£1,253
Supplemental Information
Beg. Cash£175£1,137£594£1,847
End Cash£1,556£175£1,137£594
Free Cash Flow-£1,623-£2,079-£1,712-£1,261
ValiRx plc (VAL.L) Financial Statements & Key Stats | AlphaPilot